Pages that link to "Q77666239"

The following pages link to Brian Telfer (Q77666239):

Displaying 32 items.

• Site and strain-specific variation in gut microbiota profiles and metabolism in experimental mice (Q28472438) (← links)
• ZD6474, a potent inhibitor of vascular endothelial growth factor signaling, combined with radiotherapy: schedule-dependent enhancement of antitumor activity. (Q33210440) (← links)
• Glucocorticoid receptor over-expression promotes human small cell lung cancer apoptosis in vivo and thereby slows tumor growth (Q33689201) (← links)
• Inhibition of monocarboxylate transporter-1 (MCT1) by AZD3965 enhances radiosensitivity by reducing lactate transport (Q34646307) (← links)
• A novel systemically administered Toll-like receptor 7 agonist potentiates the effect of ionizing radiation in murine solid tumor models (Q34853959) (← links)
• Inhibition of PARP-1 by olaparib (AZD2281) increases the radiosensitivity of a lung tumor xenograft. (Q35329755) (← links)
• The Clinically Active PARP Inhibitor AG014699 Ameliorates Cardiotoxicity but Does Not Enhance the Efficacy of Doxorubicin, despite Improving Tumor Perfusion and Radiation Response in Mice (Q35622211) (← links)
• The Sulfamate Small Molecule CAIX Inhibitor S4 Modulates Doxorubicin Efficacy. (Q36101549) (← links)
• Endothelial heparan sulfate 6-O-sulfation levels regulate angiogenic responses of endothelial cells to fibroblast growth factor 2 and vascular endothelial growth factor. (Q36332838) (← links)
• ZD1839 ('Iressa'), a specific oral epidermal growth factor receptor-tyrosine kinase inhibitor, potentiates radiotherapy in a human colorectal cancer xenograft model. (Q36623819) (← links)
• 17beta-Oestradiol treatment modulates nitric oxide synthase activity in MDA231 tumour with implications on growth and radiation response. (Q37352661) (← links)
• Vasoactivity of AG014699, a clinically active small molecule inhibitor of poly(ADP-ribose) polymerase: a contributory factor to chemopotentiation in vivo? (Q37373632) (← links)
• Inhibiting the phosphatidylinositide 3-kinase pathway blocks radiation-induced metastasis associated with Rho-GTPase and Hypoxia-inducible factor-1 activity. (Q39119791) (← links)
• Antimetastatic effect of sulfamate carbonic anhydrase IX inhibitors in breast carcinoma xenografts. (Q39343571) (← links)
• In vivo activation of the hypoxia-targeted cytotoxin AQ4N in human tumor xenografts. (Q39765512) (← links)
• The mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 inhibitor AZD6244 (ARRY-142886) enhances the radiation responsiveness of lung and colorectal tumor xenografts (Q39785350) (← links)
• Tirapazamine administered as a neoadjuvant to radiotherapy reduces metastatic dissemination (Q40414385) (← links)
• Viral delivery of P450 reductase recapitulates the ability of constitutive overexpression of reductase enzymes to potentiate the activity of mitomycin C in human breast cancer xenografts (Q40626842) (← links)
• A protective role for HIF-1 in response to redox manipulation and glucose deprivation: implications for tumorigenesis (Q40755887) (← links)
• Hypoxia targeted gene therapy to increase the efficacy of tirapazamine as an adjuvant to radiotherapy: reversing tumor radioresistance and effecting cure (Q44769938) (← links)
• Akt inhibition improves long-term tumour control following radiotherapy by altering the microenvironment (Q47093662) (← links)
• Enhanced response to radiotherapy in tumours deficient in the function of hypoxia-inducible factor-1 (Q47801291) (← links)
• Novel carbonic anhydrase IX-targeted therapy enhances the anti-tumour effects of cisplatin in small cell lung cancer. (Q47804424) (← links)
• Myeloid ERK5 deficiency suppresses tumor growth by blocking protumor macrophage polarization via STAT3 inhibition. (Q50420763) (← links)
• High content screening of patient-derived cell lines highlights the potential of non-standard chemotherapeutic agents for the treatment of glioblastoma. (Q52677063) (← links)
• Statin-induced metabolic reprogramming in head and neck cancer: a biomarker for targeting monocarboxylate transporters (Q59126976) (← links)
• Non-myeloablative busulfan chimeric mouse models are less pro-inflammatory than head-shielded irradiation for studying immune cell interactions in brain tumours (Q61799353) (← links)
• Abstract 3042: The novel Akt inhibitor AZD5363 following radiotherapy improves tumor control in mouse models of head and neck cancer (Q61833554) (← links)
• -Prenylation of the indole ring improves the cytotoxicity of a short antagonist G analogue against small cell lung cancer (Q62511374) (← links)
• Combining radiotherapy with AZD2171, a potent inhibitor of vascular endothelial growth factor signaling: pathophysiologic effects and therapeutic benefit (Q79794022) (← links)
• Extracellular-regulated protein kinase 5-mediated control of p21 expression promotes macrophage proliferation associated with tumor growth and metastasis (Q96608649) (← links)
• Tumor-Associated Macrophages in Osteosarcoma: From Mechanisms to Therapy (Q97897191) (← links)